What We Do
We pioneer innovative epigenetic therapies for improved healthcare outcomes. Harnessing the power of epigenetics, we’re revolutionizing disease treatment and prevention. Join us in shaping the future of medicine through cutting-edge research and patient-centric innovation.
Who We Are
EchoGenesis is the brainchild of seasoned pharmaceutical industry veterans, driven by a shared vision to transform healthcare through epigenetic therapies. Inspired by groundbreaking studies from prestigious institutions like Harvard, Johns Hopkins, and Baylor College of Medicine, our founders recognized the immense potential of epigenetics in revolutionizing disease treatment and prevention.
Established in the Maryland BioHub, EchoGenesis is dedicated to pioneering innovative solutions that leverage the dynamic regulation of epigenetics to address a wide range of health conditions.
